Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ventricular tachycardia in structurally normal hearts.

T Scott Wall1, Roger A Freedman

  • 1University of Utah Medical Center, Division of Cardiology, 50 North Medical Drive, Salt Lake City, UT 84132, USA.

Current Cardiology Reports
|August 10, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hemodynamic Consequences and Clinical Outcomes With Intravenous Lidocaine Infusion in Patients With Atrial Fibrillation.

Journal of cardiovascular electrophysiology·2026
Same author

Smartwatches and Smart Scales With Body Composition May Interfere With Cardiac Implantable Electronic Devices.

Circulation. Arrhythmia and electrophysiology·2025
Same author

Real-World Safety Profile of the Extravascular (EV) Implantable Defibrillator System: Insights From the MAUDE Database.

Circulation. Arrhythmia and electrophysiology·2025
Same author

Stroke Prevention in Subclinical Atrial Fibrillation.

The New England journal of medicine·2024
Same author

Leadless pacemaker tine damage and fracture: novel complications of a novel device fixation mechanism.

Heart rhythm O2·2024
Same author

Protocol Development and Initial Experience With Intravenous Sotalol Loading for Atrial Arrhythmias.

Critical pathways in cardiology·2023
Same journal

Diagnostic Tests for Stage B Heart Failure.

Current cardiology reports·2026
Same journal

Cardioimmunology of Myocarditis: Targeting the IL-1 Pathway.

Current cardiology reports·2026
Same journal

Antithrombotic Management in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation.

Current cardiology reports·2026
Same journal

Transcriptome Reprogramming in Heart Failure: The Hidden Splicing Code.

Current cardiology reports·2026
Same journal

Diagnosis and Management of Loeys-Dietz Syndrome: Evidence Gaps and Future Directions.

Current cardiology reports·2026
Same journal

Correction: Heart Disease in Older Women: Unique Challenges in Diagnosis and Management.

Current cardiology reports·2026
See all related articles

This review details four ventricular tachycardia syndromes in hearts without structural abnormalities. Advances in genetics and mapping enhance understanding of mechanisms and treatments for these arrhythmias.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Genetics

Background:

  • Focuses on four distinct syndromes of ventricular tachycardia in structurally normal hearts.
  • Highlights recent advances in molecular biology, genetics, and intracardiac mapping.

Purpose of the Study:

  • To review the underlying mechanisms and therapeutic options for four specific ventricular tachycardia syndromes.
  • To emphasize recent advancements in understanding and treating these conditions.

Main Methods:

  • Review of current literature on ventricular tachycardia syndromes.
  • Analysis of molecular, genetic, and electrophysiological data.
  • Discussion of intracardiac mapping techniques.

Main Results:

Related Experiment Videos

  • Cyclic AMP-mediated triggered activity tachycardias (e.g., exercise-induced right ventricular outflow tract tachycardia) are common.
  • Idiopathic left ventricular tachycardia shows re-entry in the Purkinje network, often curable with ablation.
  • Long QT syndrome involves ion channel defects causing repolarization prolongation and Torsade de Pointes.
  • Brugada syndrome results from sodium channel defects, leading to ECG abnormalities, syncope, and sudden death.

Conclusions:

  • Enhanced understanding of mechanisms and therapies for these ventricular tachycardias.
  • Catheter ablation is a key treatment for idiopathic left ventricular tachycardia.
  • Genetic and ion channel defects are central to Long QT and Brugada syndromes.